Babies on antiretroviral (ARV) treatment may be able to take breaks from ARVs without compromising their health, sparing them from toxic side effects and drug resistance.
This is according to a study by the universities of Stellenbosch and the Witwatersrand, published in today's (22 Aug) edition of the influential medical journal, The Lancet.
...
AllAfrica Subscription Content
You must be an allAfrica.com subscriber for full access to certain content.
You have selected an article from the AllAfrica archive, which requires a subscription. You can subscribe by visiting our subscription page. Or for more information about becoming a subscriber, you can read our subscription and contribution overview.
For information about our premium subscription services:
You can also freely access - without a subscription - hundreds of today's top Africa stories and thousands of recent news articles from our home page »
Already a subscriber? Sign in for full access to article